Below are the earnings highlights for Alnylam Pharmaceuticals Inc. (ALNY):
Earnings: -$111.57 million in Q3 vs. $147.75 million in the same period last year.
EPS: -$0.87 in Q3 vs. $1.15 in the same period last year.
Excluding items, Alnylam Pharmaceuticals Inc. reported adjusted earnings of -$64.20 million or -$0.50 per share for the period.
Analysts projected -$0.93 per share
Revenue: $420.146 million in Q3 vs. $313.153 million in the same period last year.
For comments and feedback: editorial@rttnews.com